LIPO
Lipella Pharmaceuticals Inc.
Set alert
0.00 USD 0.00 0.00%
0.0327 Day range 0.058
0.0002 52-week range 0.54
- YTD
- -99.67%
- 1 year
- -99.87%
- Open
- 0.058
- Prev close
- 0.0006
- Mkt cap
- 2.77K
- Vol
- 160.09K
- Avg vol
- 910
- EPS
- -2.26
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0327
- High
- 0.058
- Forward P/E
- -0.97
- Beta
- 0.00
- Short ratio
- 0.01
- Inst. own
- 0.88%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 27, 2024
- 50-d avg
- 2.98
- 200-d avg
- 4.27
- 1y target
- 10.00
Financial health
Altman Z-Score
-18.13 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.6×
FY 2019 5y median -10.6× FY 2024
P/S 6.0×
FY 2019 5y median 9.4× FY 2024
P/B 1.7×
FY 2019 5y median 3.3× FY 2024
P/FCF -0.8×
FY 2019 5y median -15.5× FY 2024
EV/EBITDA -0.2×
FY 2019 5y median -9.9× FY 2024
EV/Sales 2.0×
FY 2019 5y median 5.1× FY 2024
FCF Yield -123.6%
FY 2019 5y median -6.5% FY 2024
Profitability
Gross Margin -573.7%
FY 2019 5y median -573.7% FY 2024
Operating Margin -947.2%
FY 2019 5y median -947.2% FY 2024
Net Margin -935.2%
FY 2019 5y median -935.2% FY 2024
ROE -261.3%
FY 2019 5y median -131.0% FY 2024
ROIC -258.3%
FY 2019 5y median -110.3% FY 2024
ROA -187.6%
FY 2019 5y median -92.7% FY 2024
Growth (YoY)
Revenue 19.3%
FY 2019 FY 2024
Operating Income -7.0%
FY 2019 FY 2024
EPS (diluted) 22.2%
FY 2019 FY 2024
Free Cash Flow -24.8%
FY 2019 FY 2024
Financial Health
Current Ratio 3.5×
FY 2019 5y median 4.9× FY 2024
Quick Ratio 3.5×
FY 2019 5y median 4.9× FY 2024
Debt / Equity 0.0×
FY 2019 5y median 0.1× FY 2024
Net Debt / EBITDA 0.4×
FY 2019 5y median 0.7× FY 2024
Interest Coverage 0.0×
FY 2019 5y median -269× FY 2024
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2024
Annual · latest fiscal year ends 2024-12-31